TLDR
- Raymond James Financial increased its stake in Anheuser-Busch InBev by 24.8% during Q1, owning 929,927 shares
- Goldman Sachs upgraded BUD from neutral to buy with price target raised to $88
- BNP Paribas upgraded the stock from hold to strong-buy rating
- Company beat earnings estimates with $0.98 EPS vs $0.94 consensus but revenue fell 2.1%
- Stock currently trades at forward P/E of 16.7X with Zacks Value Style Score of B
Multiple institutional investors increased their positions in Anheuser-Busch InBev during the first quarter. Raymond James Financial led the charge with a 24.8% stake increase.
The investment firm now owns 929,927 shares valued at approximately $57.25 million. This represents 0.05% of the company’s total outstanding shares.
Several other institutions made moves on BUD stock during the same period. ABC Arbitrage SA established a new position worth $1.7 million.
Sequoia Financial Advisors boosted its holdings by 224.7%. The firm now owns 25,254 shares worth $1.6 million after adding 17,476 shares.
Merit Financial Group increased its position by 31.7%. The company purchased 3,526 additional shares, bringing its total to 14,635 shares valued at $901,000.
Pinnacle Financial Partners entered with a new $2.3 million position. Penserra Capital Management raised its stake by 24.7%, adding 506 shares to reach 2,553 total shares.
Wall Street Upgrades Signal Confidence
Analyst sentiment has shifted positively for the brewing giant. Goldman Sachs upgraded BUD from neutral to buy in May.
The investment bank raised its price target from $70.10 to $88. This represents potential upside from current trading levels.
BNP Paribas made an even stronger move in late May. The firm upgraded shares from hold directly to strong-buy rating.
Wall Street Zen provided a counterpoint by downgrading from buy to hold. Despite this, the overall analyst picture remains bullish.
Three analysts currently rate the stock as strong-buy. Six maintain buy ratings while only one holds a hold rating.
Recent Performance and Valuation Metrics
BUD shares traded up $0.79 to $63.85 on Friday. Trading volume reached 1.7 million shares, below the average of 2.9 million.
The stock has traded between $45.94 and $72.13 over the past year. Current price sits near the middle of this range.
Company financials show a market cap of $114.76 billion. The stock trades at a P/E ratio of 17.94 with a PEG ratio of 1.80.
BUD maintains a debt-to-equity ratio of 0.79. Quick ratio stands at 0.48 while current ratio reaches 0.64.
The 50-day moving average sits at $66.18. The 200-day moving average comes in at $64.13.
Zacks Research assigns BUD a Value Style Score of B. The stock also receives a VGM Score of B with a Rank #3 Hold rating.
Forward P/E ratio of 16.7X compares to the industry average of 14.1X. Price/Sales ratio stands at 1.9X with Price/Cash Flow at 9X.
Two analysts revised earnings estimates upward in the past 60 days. Zacks Consensus Estimate increased $0.16 to $3.77 per share for 2025.
The company reported Q2 earnings of $0.98 per share, beating consensus estimates of $0.94. This marked the latest in a series of earnings surprises averaging 10.1%.
Revenue declined 2.1% year-over-year during the quarter. Net margin remained healthy at 12.16% with return on equity at 16.21%.
Analysts expect full-year earnings per share of $3.37 for the current fiscal year. Consensus price target among analysts reaches $71.50.
